Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $291,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Empirical Financial Services LLC d.b.a. Empirical Wealth Management lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 16.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,125 shares of the biotechnology company’s stock after selling 223 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Axon Enterprise were worth $291,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. BKM Wealth Management LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $32,000. Key Financial Inc grew its position in Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock valued at $41,000 after purchasing an additional 125 shares in the last quarter. Lindbrook Capital LLC grew its position in Axon Enterprise by 43.3% during the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock valued at $44,000 after purchasing an additional 52 shares in the last quarter. Rakuten Securities Inc. purchased a new stake in Axon Enterprise in the 4th quarter worth approximately $48,000. Finally, Provence Wealth Management Group acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at $80,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. StockNews.com lowered Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. TheStreet cut Axon Enterprise from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. Finally, Morgan Stanley lifted their price target on shares of Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research report on Friday, April 26th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $333.08.

Check Out Our Latest Stock Analysis on AXON

Axon Enterprise Trading Down 0.9 %

Shares of AXON stock opened at $309.09 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The firm has a fifty day moving average of $310.86 and a 200-day moving average of $267.73. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The stock has a market cap of $23.32 billion, a price-to-earnings ratio of 90.38 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its quarterly earnings results on Monday, May 6th. The biotechnology company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The firm had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The company’s revenue for the quarter was up 34.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.51 earnings per share. On average, equities research analysts forecast that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.